142 related articles for article (PubMed ID: 20564032)
1. Synthetic diastereomeric-antimicrobial peptide: antibacterial activity against multiple drug resistant clinical isolates.
Park SC; Kim JY; Lee JK; Yoo S; Kim H; Seo CH; Nah JW; Hahm KS; Park Y
Biopolymers; 2011; 96(2):130-6. PubMed ID: 20564032
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.
Jeong N; Kim JY; Park SC; Lee JK; Gopal R; Yoo S; Son BK; Hahm JS; Park Y; Hahm KS
Biochem Biophys Res Commun; 2010 Sep; 399(4):581-6. PubMed ID: 20682287
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
5. Wide-spectrum antibiotic activity of synthetic, amphipathic peptides.
Tiozzo E; Rocco G; Tossi A; Romeo D
Biochem Biophys Res Commun; 1998 Aug; 249(1):202-6. PubMed ID: 9705857
[TBL] [Abstract][Full Text] [Related]
6. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
8. Design of perfectly symmetric Trp-rich peptides with potent and broad-spectrum antimicrobial activities.
Yang ST; Shin SY; Hahm KS; Kim JI
Int J Antimicrob Agents; 2006 Apr; 27(4):325-30. PubMed ID: 16563706
[TBL] [Abstract][Full Text] [Related]
9. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
Eley A; Ibrahim M; Kurdi SE; Conlon JM
Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
[TBL] [Abstract][Full Text] [Related]
10. Salt resistance and synergistic effect with vancomycin of alpha-helical antimicrobial peptide P18.
Shin SY; Yang ST; Park EJ; Eom SH; Song WK; Kim Y; Hahm KS; Kim JI
Biochem Biophys Res Commun; 2002 Jan; 290(1):558-62. PubMed ID: 11779208
[TBL] [Abstract][Full Text] [Related]
11. Novel antimicrobial peptides that exhibit activity against select agents and other drug resistant bacteria.
Venugopal D; Klapper D; Srouji AH; Bhonsle JB; Borschel R; Mueller A; Russell AL; Williams BC; Hicks RP
Bioorg Med Chem; 2010 Jul; 18(14):5137-47. PubMed ID: 20558071
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
Sader HS; Streit JM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):201-4. PubMed ID: 15541606
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
[TBL] [Abstract][Full Text] [Related]
16. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria.
Vairappan CS; Kawamoto T; Miwa H; Suzuki M
Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668
[TBL] [Abstract][Full Text] [Related]
17. Ceragenins: cholic acid-based mimics of antimicrobial peptides.
Lai XZ; Feng Y; Pollard J; Chin JN; Rybak MJ; Bucki R; Epand RF; Epand RM; Savage PB
Acc Chem Res; 2008 Oct; 41(10):1233-40. PubMed ID: 18616297
[TBL] [Abstract][Full Text] [Related]
18. Synthetic antimicrobial peptidomimetics with therapeutic potential.
Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity.
Bera S; Zhanel GG; Schweizer F
J Med Chem; 2008 Oct; 51(19):6160-4. PubMed ID: 18778047
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies.
Blondelle SE; Lohner K
Biopolymers; 2000; 55(1):74-87. PubMed ID: 10931443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
